To kick off this year's “Leadership in a Technological World” lecture series, Stuart M. Essig ‘83, President and CEO of Integra LifeSciences Holdings Corporation (NASDAQ: IART), gave a lecture titled: “Operating with Confidence: Twenty years at Integra LifeSciences” at 4:30 p.m., Wednesday, Oct. 7th, in the Friend Center Convocation Room. A reception followed in the Friend Center Atrium. Mr. Essig said that the growth of medical device companies is enabled by product innovation, new business creation, geographic expansion and acquisition and product development. He spoke at length about accelerating the organic growth of Integra with an agressive acquistion program. Watch the video.
Mr. Essig joined Integra in December 1997. Before joining Integra, Mr. Essig supervised the medical technology practice at Goldman, Sachs & Co. as a managing director. Mr. Essig had ten years of broad health care experience at Goldman Sachs, serving as a senior merger and acquisitions advisor to a broad range of domestic and international medical technology, pharmaceutical and biotechnology clients.
Mr. Essig also serves on the Board of Directors of St. Jude Medical Corporation and ADVAMED, the Advanced Medical Technology Association. Mr. Essig received an A.B. degree from the Woodrow Wilson School of Public and International Affairs at Princeton University and an M.B.A. and a Ph.D. degree in Financial Economics from the University of Chicago, Booth School of Business.
Integra LifeSciences Holdings Corporation, a world leader in regenerative medicine, is a global medical device company dedicated to improving the quality of life for millions of patients every year. Our products are used primarily in orthopedics, neurosurgery and general surgery. Headquartered in Plainsboro, New Jersey, Integra has research and manufacturing facilities throughout the world. For more information, visit www.Integra-LS.com.